News | December 26, 2023
Astellas completes acquisition of Propella Therapeutics
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Leading USA based genetic testing brand officially enters the Indian market
Subscribe To Our Newsletter & Stay Updated
